<DOC>
	<DOCNO>NCT01593306</DOCNO>
	<brief_summary>The purpose study check whether addition paclitaxel cisplatin radiation therapy improve outcome locally advance carcinoma cervix .</brief_summary>
	<brief_title>Concurrent Chemoradiotherapy With Weekly Cisplatin Versus Concurrent Chemoradiotherapy With Weekly Cisplatin Paclitaxel Locally Advanced Carcinoma Cervix</brief_title>
	<detailed_description>Carcinoma cervix 2nd common malignancy among female 86 % burden occur develop country . India account 27 % world cervical cancer burden ; locally advance stage ie stage IIA IVA . Significant development radiation technique addition cisplatin base chemotherapy radiation schedule lead improved survival still far satisfactory 20 25 % patient fail locally 10 20 % patient fail distant site . Novel technique require improve dismal rate . Thus investigator intend use combination chemotherapy paclitaxel cisplatin , consider paclitaxel taxane show good efficacy solid tumor ovary , lung breast ; also show radiosensitizing effect cervical cancer cell line also show effective phase III trial cisplatin metastatic recurrent carcinoma cervix .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>histologically proven carcinoma cervix age 18 year 65 year stage IIA , IIB , IIIA &amp; IIIB accord FIGO 2009 age &gt; 65 year &lt; 18 year stage IA , IB , IVA &amp; IVB Histology squamous cell , adenocarcinoma adenosquamous carcinoma history prior pelvic surgery cancer , prior pelvic radiotherapy prior chemotherapy . derange renal function test liver function test KPS &gt; = 60 distant metastasis</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2012</verification_date>
</DOC>